{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:14:07Z","timestamp":1792725247796,"version":"4.5.0"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1093\/jac\/dkq345","type":"journal-article","created":{"date-parts":[[2010,9,19]],"date-time":"2010-09-19T00:14:53Z","timestamp":1284855293000},"page":"2556-2565","source":"Crossref","is-referenced-by-count":164,"title":["Rifaximin modulates the colonic microbiota of patients with Crohn's disease: an in vitro approach using a continuous culture colonic model system"],"prefix":"10.1093","volume":"65","author":[{"given":"Simone","family":"Maccaferri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annett","family":"Klinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Kolida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice","family":"Ndagijimana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Laghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorella","family":"Calanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Brigidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn R.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele","family":"Costabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2010,9,18]]},"reference":[{"key":"key\n\t\t\t\t20170511114159_DKQ345C1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/QCO.0b013e32832a8a5d","article-title":"Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases","volume":"22","author":"Packey","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11894-007-0066-4","article-title":"Microbial host interactions in IBD: implications for pathogenesis and therapy","volume":"9","author":"Sartor","year":"2007","journal-title":"Curr Gastroenterol Rep"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2005.073817","article-title":"Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach","volume":"55","author":"Manichanh","year":"2006","journal-title":"Gut"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C4","doi-asserted-by":"crossref","first-page":"13780","DOI":"10.1073\/pnas.0706625104","article-title":"Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases","volume":"104","author":"Frank","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C5","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"B\u00e4ckhed","year":"2005","journal-title":"Science"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ibd.20330","article-title":"Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora","volume":"14","author":"Swidsinski","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C7","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11894-006-0039-z","article-title":"The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease","volume":"8","author":"Ewaschuk","year":"2006","journal-title":"Curr Gastroenterol Rep"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1365-2036.2003.01793.x","article-title":"Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease","volume":"18","author":"Dejaco","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00054725-200405000-00022","article-title":"The role of antibiotics in the management of Crohn's disease","volume":"10","author":"Wild","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C10","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/j.1365-2036.2006.02879.x","article-title":"Antibiotic treatment of Crohn's disease: results of a multicentre, double blind, randomized, placebo-controlled trial with rifaximin","volume":"23","author":"Prantera","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2165\/00003495-199549030-00009","article-title":"Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria","volume":"49","author":"Gillis","year":"1995","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000081990","article-title":"Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential","volume":"51","author":"Scarpignato","year":"2005","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C13","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.2165\/00003495-200565120-00011","article-title":"Rifaximin: a review of its use in the management of traveller's diarrhoea","volume":"65","author":"Robins","year":"2005","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000081997","article-title":"Management of diverticular disease: is there room for rifaximin","volume":"51","author":"Papi","year":"2005","journal-title":"Chemotherapy"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2036.2000.00751.x","article-title":"Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth","volume":"14","author":"Di Stefano","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C16","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1185\/030079905X53252","article-title":"An open-label evaluation of rifaximin in the treatment of active Crohn's disease","volume":"21","author":"Shafran","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0016-5085(00)85267-1","article-title":"Combination of antibiotic and probiotic treatment is efficacious in prophylaxis of post-operative recurrence of Crohn's disease: a randomized controlled study versus mesalazine","volume":"118","author":"Campieri","year":"2000","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C18","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/138161209788168173","article-title":"The role of gut microbiota in drug response","volume":"15","author":"Wilson","year":"2009","journal-title":"Curr Pharm Des"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C19","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s002489900072","article-title":"Validation of a three-stage compound continuous culture system for investigating the effect of retention time on the ecology and metabolism of bacteria in the human colon","volume":"35","author":"Macfarlane","year":"1998","journal-title":"Microb Ecol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/jac\/dkg267","article-title":"Effects of cefotaxime and desacetylcefotaxime upon Clostridium difficile proliferation and toxin production in a triple-stage chemostat model of the human gut","volume":"52","author":"Freeman","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C21","first-page":"608","article-title":"In vitro fermentation of carbohydrates by porcine faecal inocula and their influence on Salmonella Typhimurium growth in batch culture systems","volume-title":"FEMS Microbiol Ecol","author":"Martin-Pelaez","year":"2008"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C22","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/AEM.66.1.297-303.2000","article-title":"Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers","volume":"66","author":"Walter","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C23","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1574-6941.2003.tb01062.x","article-title":"Effect of fermentable carbohydrates on piglet faecal bacterial communities as revealed by denaturing gradient gel electrophoresis analysis of 16S ribosomal DNA","volume":"43","author":"Konstantinov","year":"2003","journal-title":"FEMS Microbiol Ecol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C24","volume-title":"Measuring Biological Diversity","author":"Magurran","year":"2004"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C25","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1128\/AEM.62.10.3668-3672.1996","article-title":"Specific detection and analysis of a probiotic Bifidobacterium strain in infant feces","volume":"62","author":"Kok","year":"1996","journal-title":"Appl Environ Microbiol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C26","doi-asserted-by":"crossref","first-page":"14422","DOI":"10.1073\/pnas.212527599","article-title":"The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract","volume":"99","author":"Schell","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C27","first-page":"19","article-title":"Gut fermentation products of inulin-derived prebiotics beneficially modulate markers of tumour progression in human colon tumor cells","volume":"1","author":"Klinder","year":"2004","journal-title":"Int J Canc Prevent"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C28","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0014-4827(88)90265-0","article-title":"A simple technique for quantitation of low levels of DNA damage in individual cells","volume":"175","author":"Singh","year":"1988","journal-title":"Exp Cell Res"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C29","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1017\/S0007114507793923","article-title":"Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study","volume":"99","author":"Costabile","year":"2008","journal-title":"Br J Nutr"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C30","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1128\/AEM.02793-08","article-title":"Different fecal microbiota and volatile organic compounds in treated and untreated children with celiac disease","volume":"75","author":"Di Cagno","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C31","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1096\/fj.06-6927com","article-title":"Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease","volume":"21","author":"Garner","year":"2007","journal-title":"FASEB J"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijfoodmicro.2009.04.016","article-title":"Effect of a synbiotic food consumption on human gut metabolic profiles evaluated by 1H nuclear magnetic resonance spectroscopy","volume":"134","author":"Ndagijimana","year":"2009","journal-title":"Int J Food Microbiol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C34","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1021\/pr060470d","article-title":"Rapid and noninvasive metabonomic characterization of inflammatory bowel disease","volume":"6","author":"Marchesi","year":"2007","journal-title":"J Proteome Res"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/AAC.00306-08","article-title":"Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model","volume":"53","author":"Saxton","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/jac\/dkn502","article-title":"Activity of vancomycin against epidemic Clostridium difficile strains in a human gut model","volume":"63","author":"Baines","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/jac\/dki321","article-title":"Comparison of the efficacy of ramoplanin and vancomycin in both in vitro and in vivo models of clindamycin-induced Clostridium difficile infection","volume":"56","author":"Freeman","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C38","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/jac\/dkn358","article-title":"Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model","volume":"62","author":"Baines","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C39","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1093\/jac\/dki120","article-title":"Effects of piperacillin\/tazobactam on Clostridium difficile growth and toxin production in a human gut model","volume":"55","author":"Baines","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 3 Pt 1","key":"key\n\t\t\t\t20170511114159_DKQ345C40","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1097\/MCG.0b013e31816d922c","article-title":"Understanding why probiotic therapies can be effective in treating IBD","volume":"42","author":"Fedorak","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrmicro2047","article-title":"Genome-scale analyses of health-promoting bacteria: probiogenomics","volume":"7","author":"Ventura","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C42","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1128\/AEM.66.4.1654-1661.2000","article-title":"Phylogenetic relationship of butyrate producing bacteria from the human gut","volume":"66","author":"Barcenilla","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C43","doi-asserted-by":"crossref","first-page":"16731","DOI":"10.1073\/pnas.0804812105","article-title":"Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients","volume":"105","author":"Sokol","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C44","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1128\/AEM.66.10.4523-4527.2000","article-title":"Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups","volume":"66","author":"Harmsen","year":"2000","journal-title":"Appl Environ Microbiol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C45","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1128\/AAC.44.8.2205-2206.2000","article-title":"In vitro activity and fecal concentration of rifaximin after oral administration","volume":"44","author":"Jiang","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1128\/AAC.00441-08","article-title":"Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora","volume":"53","author":"Finegold","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1179\/joc.2002.14.3.290","article-title":"Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis","volume":"14","author":"Brigidi","year":"2002","journal-title":"J Chemother"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C48","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ijantimicag.2009.11.013","article-title":"Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei","volume":"35","author":"Jiang","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C49","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1128\/AAC.00691-09","article-title":"Pretreatment of epithelial cells with rifaximin alters bacterial attachment and internalization profiles","volume":"54","author":"Brown","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C50","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/00365520802321204","article-title":"Involvement of central immunity in uncomplicated diverticular disease","volume":"44","author":"Cianci","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijantimicag.2008.10.007","article-title":"Immunoregolatory activity of rifaximin associated with a resistant mutant of Bifidobacterium infantis","volume":"33","author":"Vitali","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00075197-200409000-00009","article-title":"The butyrate story: old wine in new bottles?","volume":"7","author":"Scheppach","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C53","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2036.2006.03042.x","article-title":"Review article: prebiotics in the gastrointestinal tract","volume":"24","author":"Macfarlane","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2174\/138920009787048383","article-title":"Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics","volume":"10","author":"Jacobs","year":"2009","journal-title":"Curr Drug Metab"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C55","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00726-006-0477-9","article-title":"Effects of amino acid-derived luminal metabolites on the colonic epithelium and physiopathological consequences","volume":"33","author":"Blachier","year":"2007","journal-title":"Amino Acids"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C56","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1021\/pr801068x","article-title":"Panorganismal gut microbiota-host metabolic crosstalk","volume":"8","author":"Martin","year":"2009","journal-title":"J Proteome Res"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C57","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jn\/129.1.77","article-title":"Bacteria used for the production of yogurt inactivate carcinogens and prevent DNA damage in the colon of rats","volume":"129","author":"Wollowski","year":"1999","journal-title":"J Nutr"},{"key":"key\n\t\t\t\t20170511114159_DKQ345C58","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.mrfmmm.2004.03.010","article-title":"Antigenotoxicity of probiotics and prebiotics on faecal water-induced DNA damage in human colon adenocarcinoma cells","volume":"51","author":"Burns","year":"2004","journal-title":"Mutat Res"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/65\/12\/2556\/16862116\/dkq345.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T22:32:59Z","timestamp":1591914779000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkq345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,18]]},"references-count":58,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2010,9,18]]},"published-print":{"date-parts":[[2010,12]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkq345","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9,18]]}}}